Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Frontiers in Oncology|October 4, 2021
Salvage Therapy With Polatuzumab Vedotin, Bendamustine, and Rituximab Prior to Allogeneic Hematopoietic Transplantation in Patients With Aggressive Lymphomas Relapsing After Therapy With Chimeric Antigen Receptor T-Cells-Report on Two CasesKristin Gerhardt, Madlen Jentzsch, Thomas Georgi, et al.
Stem Cell Reports|September 25, 2020
Precise Correction of Heterozygous SHOX2 Mutations in hiPSCs Derived from Patients with Atrial Fibrillation via Genome Editing and Sib SelectionSimon Alexander Sumer, Sandra Hoffmann, Svenja Laue, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 10, 2015
Combination Therapy for Graft-versus-Host Disease Prophylaxis with Etanercept and Extracorporeal Photopheresis: Results of a Phase II Clinical TrialCarrie L Kitko, Thomas Braun, Daniel R Couriel, et al.
Frontiers in Genetics|July 30, 2019
Functional Characterization of Rare Variants in the <i>SHOX2</i> Gene Identified in Sinus Node Dysfunction and Atrial FibrillationSandra Hoffmann, Christoph Paone, Simon A Sumer, et al.
Journal of Cancer Research and Clinical Oncology|January 20, 2023
Prognostic value of baseline and early response FDG-PET/CT in patients with refractory and relapsed aggressive B-cell lymphoma undergoing CAR-T cell therapyThomas Walter Georgi, Lars Kurch, Georg-Nikolaus Franke, et al.
Basic Research in Cardiology|May 4, 2016
Coding and non-coding variants in the SHOX2 gene in patients with early-onset atrial fibrillationSandra Hoffmann, Sebastian Clauss, Ina M Berger, et al.
PLOS Global Public Health|April 9, 2025
Quantifying national burdens of foodborne disease-Four imperatives for global impactKaren H Keddy, Sandra Hoffmann, Luria Leslie Founou, et al.
Hemasphere|June 16, 2025
Prognostic significance of PET/CT for CAR T cell therapy in relapsed/refractory multiple myelomaPatrick Born, David Fandrei, Song Yau Wang, et al.
Transfusion|July 29, 2025
Impact of cellular composition and T-cell senescence of mononuclear cell concentrates on the manufacturing process of chimeric antigen receptor (CAR) T-cellsVladan Vučinić, Theresa Tumewu, Mandy Brückner, et al.
Blood Cancer Discovery|October 23, 2024
Bispecific Antibodies as Bridging to BCMA CAR-T Cell Therapy for Relapsed/Refractory Multiple MyelomaDavid Fandrei, Sabine Seiffert, Michael Rade, et al.
Pageof 9